Skip to content

Attention

The medical device and therapy related information on this website is aimed exclusively at healthcare professionals.

Not all products are cleared or available for sale in all Asia Pacific countries.

By clicking on the button "Accepted and Confirmed" you assure that you have taken note of this information and that you are a healthcare professional.

Fluid management may lead to:

Improved patient well-being

Less intradialytic complications and hypotensive episodes

Better control of hypertension

Reduction in antihypertensive medication Reduced cardiovascular mortality

Significant Observations from Physicians Using the BCM

The BCM, utilizing advanced bioimpedance technology, has been shown to be an important tool in helping to provide both objective and reliable information needed in determination of dry weight. This has the potential to help in limiting the repetitive cycle involved in the probing process and, thus possibly reduce chances of hypotensive events that may lead to cardiovascular issues.

“No heart attacks were observed and no emergency dialysis occurred, and the number of intra-dialytic complications such as hypotension were reduced with the assistance of the BCM in the assessment of fluid status in a group of HD patients2.”

“Volume control guided by objective assessment of fluid overload (with the BCM) showed significant decrease in left ventricular mass and improved BP control3.”

“Assessment of fluid overload with bioimpedance spectroscopy (BCM) provides better management of fluid status, which leads to significant improvement in the cardiovascular status of HD patients – Hur, et al3.”

Cost-saving potential of fluid management

In dialysis patients, fluid overload is associated with acute complications including congestive heart failure and pulmonary oedema. Fluid overload can require emergency dialysis outside of the routine dialysis sessions. These additional treatments are common and expensive. In an US investigation, the total cost in the study period of two years was approximately $266 million4.

BCM-Body Composition Monitor

From technology to therapy

Body weight and BMI (Body Mass Index) do not differentiate between muscle, fat and water. In addition, body composition is often described in terms of fat free mass (FFM) and fat mass (Fat) only, not considering over-hydration.

The BCM – Body Composition Monitor is the first device on the market to distinguish the muscle mass from pathologic fluid overload. This is of special interest for detecting malnutrition in chronic kidney disease patients. The BCM - Body Composition Monitor separates excess fluid (over-hydration) from the lean and adipose tissue components of the body on the basis of a unique body composition model.

Learn more about the Body Composition Monitor

BCM – Utilizing cutting-edge bioimpedance technology

For CKD patients

Including Peritoneal Dialysis (PD) and Hemodialysis (HD)

Captures trending information

For better ongoing patient management

Potentially shortens the initial trial-and-error phase

In determining the optimal dry weight in incident dialysis patients

The BCM - Body Composition Monitor separates excess fluid (over-hydration) from the lean and adipose tissue components of the body on the basis of a unique body composition model.

BCM — Body Composition Monitor

BCM — Body Composition Monitor

The BCM – Body Composition Monitor The Body Composition Monitor is the first device on the market to distinguish the muscle mass from pathologic fluid overload. This is of special interest for detecting malnutrition in chronic kidney disease patients.

The three compartments

The three compartments

Body weight = Lean Tissue Mass + Adipose Tissue Mass + Over-hydration The three compartments (LTM, ATM and OH) are identified from measurements of body weight, height, intracellular (ICW) and extracellular water (ECW) determined by whole body bioimpedance spectroscopy (BIS).  

1 Wizemann V. et al., Nephrology Dialysis Transplantation (2009); 24: 1574-1579
2 Machek P, et al, 2008 Optimal Fluid Status Assessed with Bioimpedance Spectroscopy Reduces IMES and Hospitalization in Hemodialysis Patients, XLV-ERA-EDTA-Congress Poster MP 266
3 Hur E, et al, 2013 Effect of Fluid Management Guided by Bioimpedance Spectroscopy on Cardiovascular Parameters in Hemodialysis Patients:  A Randomized Controlled Trail, Am J Kidney Dis; 61: 957-965.
4 Arneson T. et al., Clinical Journal of the American Society of Nephrology (2010); 5: 1054-1063.